These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 17105984)

  • 21. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
    Boccia S; Hung R; Ricciardi G; Gianfagna F; Ebert MP; Fang JY; Gao CM; Götze T; Graziano F; Lacasaña-Navarro M; Lin D; López-Carrillo L; Qiao YL; Shen H; Stolzenberg-Solomon R; Takezaki T; Weng YR; Zhang FF; van Duijn CM; Boffetta P; Taioli E
    Am J Epidemiol; 2008 Mar; 167(5):505-16. PubMed ID: 18162478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
    Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
    Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
    Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):427-33. PubMed ID: 10794488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study.
    van den Donk M; Buijsse B; van den Berg SW; Ocké MC; Harryvan JL; Nagengast FM; Kok FJ; Kampman E
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1562-6. PubMed ID: 15941973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
    Martínez ME; Thompson P; Jacobs ET; Giovannucci E; Jiang R; Klimecki W; Alberts DS
    Gastroenterology; 2006 Dec; 131(6):1706-16. PubMed ID: 17087956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis.
    Zintzaras E
    Clin Genet; 2006 Apr; 69(4):327-36. PubMed ID: 16630166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-related genes and the risk of tobacco-related cancers in Central Europe.
    Hung RJ; Hashibe M; McKay J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates I; Foretova L; Janout V; Bencko V; Chabrier A; Moullan N; Canzian F; Hall J; Boffetta P; Brennan P
    Carcinogenesis; 2007 Jun; 28(6):1334-40. PubMed ID: 17389614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of soy intake and breast cancer risk.
    Trock BJ; Hilakivi-Clarke L; Clarke R
    J Natl Cancer Inst; 2006 Apr; 98(7):459-71. PubMed ID: 16595782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population.
    Deligezer U; Akisik EE; Dalay N
    In Vivo; 2005; 19(5):889-93. PubMed ID: 16097444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study.
    Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
    Bone; 2005 Mar; 36(3):577-83. PubMed ID: 15777680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition.
    Vollset SE; Igland J; Jenab M; Fredriksen A; Meyer K; Eussen S; Gjessing HK; Ueland PM; Pera G; Sala N; Agudo A; Capella G; Del Giudice G; Palli D; Boeing H; Weikert C; Bueno-de-Mesquita HB; Carneiro F; Pala V; Vineis P; Tumino R; Panico S; Berglund G; Manjer J; Stenling R; Hallmans G; Martínez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Allen N; Key TJ; Bingham S; Linseisen J; Kaaks R; Overvad K; Tjønneland A; Büchner FL; Peeters PH; Numans ME; Clavel-Chapelon F; Boutron-Ruault MC; Trichopoulou A; Lund E; Slimani N; Ferrari P; Riboli E; González CA
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2416-24. PubMed ID: 18006931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
    Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
    Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms.
    Shi Q; Zhang Z; Li G; Pillow PC; Hernandez LM; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1477-84. PubMed ID: 15941959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk.
    Levine AJ; Siegmund KD; Ervin CM; Diep A; Lee ER; Frankl HD; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):657-63. PubMed ID: 10919734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
    Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
    Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis.
    Sun L; Sun YH; Wang B; Cao HY; Yu C
    Eur J Cancer Prev; 2008 Oct; 17(5):446-52. PubMed ID: 18714187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer.
    Webb PM; Ibiebele TI; Hughes MC; Beesley J; van der Pols JC; Chen X; Nagle CM; Bain CJ; Chenevix-Trench G; ;
    Eur J Clin Nutr; 2011 Oct; 65(10):1133-40. PubMed ID: 21629268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea.
    Kim DH; Ahn YO; Lee BH; Tsuji E; Kiyohara C; Kono S
    Cancer Lett; 2004 Dec; 216(2):199-205. PubMed ID: 15533596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
    Ren A; Wang J
    Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
    Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
    Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.